Method and pharmaceutical composition for use in the treatment of cancer

US9198949B2 · kind B2 · utility

Assignees

• INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
• Université Pierre et Marie Curie · FR
• UNIVERSITÉ PARIS DIDEROT—PARIS 7 · FR
• UNIVERSITE DE PARIS DESCARTES · FR
• ASSISTANCE PUBLIQUE—HÔPITAUX DE PARIS (APHP) · FR

Inventors

• Santos Susin · Paris, FR
• Pierre Launay · Paris, FR
• Philippe Karoyan · Paris, FR
• Helene Merle-Beral · Paris, FR

Key dates

• Filing date: Jun 6, 2013
• Grant date: Dec 1, 2015
• Expiry date: Jun 6, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K48/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a soluble peptide comprising the amino acids sequence: KRFYVVMWKK (SEQ ID NO: 1) or a function-conservative variant thereof for use in the treatment of cancer. The invention also relates to a pharmaceutical composition for use in the treatment of cancer comprising at least one soluble peptide according to the invention or at least one acid nucleic according to the invention or at least one expression vector according to the invention, or at least one host cell according to the invention and a pharmaceutically acceptable carrier.